全价值链运营

Search documents
中集车辆(301039) - 2025年5月9日投资者关系活动记录表
2025-05-12 08:30
Group 1: Investor Relations Activities - The company participated in multiple roadshows and strategy meetings from May 7 to May 9, 2025, in Shanghai, Hangzhou, and Beijing [2][3] - Key participants included various securities firms and investment funds such as Huafu Securities, Vanguard Fund, and others [2][3] Group 2: Q1 2025 Performance Highlights - The EV·DTB superstructure business achieved sales of 6,000 units, a year-on-year increase of 11.6%, with revenue reaching 660 million CNY and contributing a gross profit of 20 million CNY [3][4] - In North America, the company sold 4,156 semi-trailers, generating revenue of 18 million USD, despite a declining market with a fifth consecutive quarter of decreased trailer registrations [4] Group 3: Strategic Developments - The company is focusing on enhancing its supply chain resilience in North America by increasing local procurement and establishing backup supplies in Thailand and Canada [4] - The development of the pure electric head-mounted train (EV-RT2.0) is underway, with market research and product testing already initiated [5][6] Group 4: Future Growth Opportunities - The company identifies significant growth opportunities in the unified national market and global southern markets, planning to leverage initiatives like the "Starlink Plan" and "Xiongqi Plan" to maximize value across the semi-trailer value chain [6] - The company aims to transform into a preferred partner for new energy heavy-duty truck chassis, focusing on innovation and strategic partnerships [6]
云南白药(000538) - 2025年4月8日调研活动附件之投资者调研会议记录(一)
2025-04-09 09:14
云南白药集团股份有限公司 投资者调研会议记录 时间:2025 年 4 月 8 日 地点:集团总部办公大楼 2、请问公司药品事业群主要产品在 2024 年的销售情况如何? 会议内容 1、请介绍一下公司 2024 年经营情况。 答:2024 年,公司克服外部环境剧烈变化带来的挑战,聚焦制 药核心,通过全产业链、全价值链、全生产要素的卓越运营,保持强 劲增长。报告期内,实现营业收入 400.33 亿元,较上年同期增长 2.36%; 实现归母净利润 47.49 亿元,较上年同期的 40.94 亿元同比增长 16.02%;扣非归母净利润 45.23 亿元,较上年同期的 37.64 亿元同比 增长 20.18%,创历史新高。 从成长质量来看,报告期内公司经营性现金流净额为 42.97 亿元, 较上年同期增长 22.68%;加权平均净资产收益率 11.99%,较上年同 期提升 1.48 个百分点;基本每股收益 2.66 元/股,较上年同期增长 16.16%。与此同时,公司业务结构持续优化,工业收入占营业收入比 重进一步提升至 36.14%,工业收入增速达 5.30%;工业毛利率 65.93%, 较上年同期增长 1.69 个 ...